Corbus Pharmaceuticals Holdings Inc — Financial Statements (NASDAQ:CRBP) | MetaTrader

Open full chart

Nachrichten

Corbus Pharmaceuticals: Aktie steigt nach vielversprechenden Sicherheitsdaten zu Adipositas-Medikament

Corbus Pharmaceuticals stock rises after promising obesity drug safety data

Corbus reports positive phase 1 results for obesity drug CRB-913

Corbus to release phase 1a study results for obesity drug CRB-913

Corbus Pharmaceuticals: Data Update, Fundraising Do Not Diminish The Thesis

Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP)

Corbus Pharmaceuticals: Aktie bricht nach 75-Millionen-Dollar-Kapitalerhöhung ein

Corbus Pharmaceuticals stock plunges after $75 million public offering

Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Cooper-Standard Holdings (NYSE:CPS), Aptiv (NYSE:APTV)

Corbus platziert Kapitalerhöhung über 75 Millionen US-Dollar

Corbus prices $75 million public offering of common stock

Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Ardelyx (NASDAQ:ARDX), Amazon.com (NASDAQ:AMZN)